Stay updated on Nivolumab in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays a revision tag v3.6.6, replacing the previous v3.6.5, signaling a small update to the listing's metadata or presentation.
    Difference
    0.0%
    Check dated 2026-08-30T21:56:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 in the page metadata.
    Difference
    0.0%
    Check dated 2026-08-09T09:17:06.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, indicating a new version of the page snapshot. This appears to be a metadata change rather than a substantive update to the study details.
    Difference
    0.0%
    Check dated 2026-07-25T18:15:35.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page footer now displays revision v3.6.3 instead of v3.6.2, indicating a small release update to the page.
    Difference
    0.0%
    Check dated 2026-07-04T13:32:32.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0, indicating an update to the page’s template/versioning.
    Difference
    0.0%
    Check dated 2026-06-27T08:07:46.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The study page now indicates that recruitment has ended and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). The Study Plan area is updated to include an Intervention/Treatment label, and the revision note updates to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-13T01:29:27.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.